Pulocimab
Modify Date: 2024-04-03 07:53:02
Pulocimab structure
|
Common Name | Pulocimab | ||
|---|---|---|---|---|
| CAS Number | 2428381-49-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PulocimabPulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers[1]. |
| Name | Pulocimab |
|---|
| Description | Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR2 |
| References |
[1]. Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82(12):1333-1339. |
| No Any Chemical & Physical Properties |